Liver Transplant for Cholestatic Liver Diseases

Andres F. Carrion, Kalyan Ram Bhamidimarri

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations


Cholestatic liver diseases include a group of diverse disorders with different epidemiology, pathophysiology, clinical course, and prognosis. Despite significant advances in the clinical care of patients with cholestatic liver diseases, liver transplant (LT) remains the only definitive therapy for end-stage liver disease, regardless of the underlying cause. As per the United Network for Organ Sharing database, the rate of cadaveric LT for cholestatic liver disease was 18% in 1991, 10% in 2000, and 7.8% in 2008. This review summarizes the available evidence on various common and rare cholestatic liver diseases, disease-specific issues, and pertinent aspects of LT.

Original languageEnglish (US)
Pages (from-to)345-359
Number of pages15
JournalClinics in liver disease
Issue number2
StatePublished - May 1 2013


  • Cholestatic liver disease
  • Liver transplantation
  • Outcomes
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis
  • Recurrence

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'Liver Transplant for Cholestatic Liver Diseases'. Together they form a unique fingerprint.

Cite this